| Literature DB >> 28769999 |
Roy Spijkerman1, Michel Paul Johan Teuben1, Fatima Hoosain2, Liezel Phyllis Taylor2, Timothy Craig Hardcastle3, Taco Johan Blokhuis1, Brian Leigh Warren2, Luke Petrus Hendrikus Leenen1.
Abstract
BACKGROUND: Selective non-operative management (NOM) for the treatment of blunt splenic trauma is safe. Currently, the feasibility of selective NOM for penetrating splenic injury (PSI) is unclear. Unfortunately, little is known about the success rate of spleen-preserving surgical procedures. The aim of this study was to investigate the outcome of selective NOM for penetrating splenic injuries.Entities:
Keywords: Gunshot wound; Mortality; Non-operative; Penetrating; Spleen; Stab wound; Trauma
Mesh:
Year: 2017 PMID: 28769999 PMCID: PMC5526240 DOI: 10.1186/s13017-017-0144-3
Source DB: PubMed Journal: World J Emerg Surg ISSN: 1749-7922 Impact factor: 5.469
Fig. 1Treatment protocol
Comparison of baseline characteristics
| Group 1: Splenectomy ( | Group 2: Spleen-preserving surgical therapy ( | Group 3: Non-operative management ( | |
|---|---|---|---|
| Age (years) | 29 (22–34)a | 26 (19–30)a | 26 (20–32) |
| Gender (M/F) | 42/3 | 47/4 | 20/2 |
| SBP (mmHg) | 117 (94–137)a | 129 (115–141)a ,Φ | 117 (105–124)Φ |
| Pulse rate (bpm) | 103 (82–124)a | 89 (74–108)a | 98 (83–106) |
| GCS | 15 (14–15)† | 15 (15–15)† | 15 (15–15) |
| Serum Hb (g/dL) | 11 (9.2–12.7) | 11.5 (9.7–13.4) | 11.8 (10–12.8) |
| Thrombocytes count (×109/L) | 212 (124–290)a ,‡ | 274 (208–319)a | 281 (208–391)‡ |
| AIS spleen | 4 (3–5)† | 2 (2–3)†,∞ | 3 (2–4)∞ |
| ISS | 25 (19–36)a | 18 (13–25)a | 27 (18–41) |
All variables are in median (IQR)
SBP systolic blood pressure, bpm beats per minute, GCS Glasgow Coma Score, Hb haemoglobin, Ht haematocrit, ISS Injury Severity Score, AIS Abbreviated Injury Score
Group 1 vs. group 2 with p < 0.05 by a t test and †Mann-Whitney U test
Group 2 vs. group 3 with p < 0.05 by ∞ t test and ΦMann-Whitney U test
Group 1 vs. group 3 with p < 0.05 by ‡ t test
Mechanism of injury
| Stab wounds | Gunshot wounds | |
|---|---|---|
| Total splenectomy | 10 | 35 |
| Spleen-preserving therapy | 31 | 20 |
| Non-operative management | 12 | 10 |
| Total number of complications | 6a | 50a |
| No. of patients with complications | 5 | 27 |
| Ventilation days | 0 (0–0)∞ | 1 (0–3)∞ |
| ICU stay (days) | 0 (0–0)∞ | 3 (1–8)∞ |
| Length of hospital stay (days) | 6 (5–9)∞ | 9 (6–18)∞ |
| Mortality | 0† | 7† |
All variables are in median (IQR). All frequencies are in absolute number
ICU intensive care unit
p < 0.05 by achi-square test, †Fisher’s exact test and ∞Mann-Whitney U test
Associated injuries
| Group 1: Splenectomy ( | Group 2: Spleen-preserving surgical therapy ( | Group 3: Non-operative management ( | |
|---|---|---|---|
| Abdominal solid organ injuries | |||
| Kidney | 29 | 20 | 10 |
| Liver | 18 | 10 | 3 |
| Pancreas | 16 | 7 | 1 |
| Abdominal hollow organ injuries | |||
| Stomach | 22 | 15 | 0 |
| Colon | 16 | 12 | 0 |
| Small bowel | 6 | 7 | 0 |
| Duodenum | 1 | 0 | 0 |
| Extra-abdominal injuries | |||
| Lung | 32 | 43 | 18 |
| Diaphragm | 33 | 35 | 5 |
| Spine | 7 | 6 | 7 |
| Craniocerebral | 2 | 1 | 4 |
| Heart | 2 | 0 | 0 |
| Neck | 2 | 1 | 0 |
| Maxillofacial | 1 | 0 | 1 |
| Ureter | 1 | 0 | 0 |
Fig. 2Flowchart
Comparison of outcome between treatment groups
| Group 1: Splenectomy ( | Group 2: Spleen-preserving surgical therapy ( | Group 3: Non-operative management ( | |
|---|---|---|---|
| Total number of complications | 30 | 21 | 5 |
| No. of patients with complications | 19a | 9a | 4 |
| Ventilation days | 1 (0–3)∞ | 0 (0–1) | 0 (0–0)∞ |
| ICU stay (days) | 2 (0–6)∞ | 0 (0–3) | 0 (0–1)∞ |
| Length of hospital stay (days) | 8 (7–12) | 7 (5–12) | 8 (5–15) |
| Mortality | 7† | 0† | 0 |
All variables are in median (IQR). All frequencies are in absolute number
ICU intensive care unit
Group 1 vs. group 2 with p < 0.05 by achi-square test and †Fisher’s exact test
Group 1 vs. group 3 with p < 0.05 by Mann-Whitney U test
Post-operative complications
| Group 1: Splenectomy ( | Group 2: Spleen-preserving surgical therapy ( | Group 3: Non-operative management ( | |
|---|---|---|---|
| Intra-abdominal collections | 7 | 7 | 2 |
| Perisplenic | 5 | 1 | 1 |
| Other location | 3 | 6 | 1 |
| Sepsis | 6 | 3 | 1 |
| Pneumonia | 2 | 2 | 2 |
| Ileus | 3 | – | – |
| MODS | 3 | – | – |
| Wound infection | 1 | 2 | – |
| Ongoing bleeding | 2 | – | – |
| Re-bleed | 2 | – | – |
| Subglottic stenosis | – | 2 | – |
| Renal pseudo aneurysm | 1 | – | – |
| Lung empyema | 1 | 1 | – |
| Upper GI bleed | 1 | – | – |
| Enterocutaneous fistula | 1 | – | – |
| Exudative pleural adhesions | – | 1 | – |
| Extra-abdominal collections | – | 1 | – |
| Infected urinoma | – | 1 | – |
| Urinoma | – | 1 | – |
All frequencies are in absolute number
MODS multi-organ dysfunction syndrome, GI gastrointestinal